María Araceli Caballero-Rabasco

Profesor asociado

Universitat Pompeu Fabra

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

María Araceli Caballero-Rabasco is an associated professor at Universitat Pompeu Fabra in Spain (country code: 34). Her research focuses on pediatric asthma management, including the effectiveness of immunotherapy and digitally supported interventions, as well as the diagnosis and treatment of exercise-induced laryngeal obstruction. She is also involved in studies addressing inhalation techniques, treatment adherence, and the cost-effectiveness of asthma treatments in children.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Collaborators (4)

Alexandra Lelia Dima

Serra Hunter Lecturer

University of Barcelona

SPAIN

View details

Victor Zamora

Institut Hospital del Mar d'Investigacions Mèdiques

SPAIN

View details

Laura Moreno-Galarraga

Profesor asociado

Universidad de Navarra

SPAIN

View details

Yolanda Pardo

Professor

University of Barcelona

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

María Araceli Caballero-Rabasco

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Subcutaneous House Dust Mite Immunotherapy Effectiveness and Safety in a Paediatric Population: A Prospective Real-Life Study

Efficacy of a Digitally Supported Intervention for Children and Adolescents With Difficult-to-control Asthma (INSPIRINGKIDS): Results From a Multicentre Randomized Controlled Trial.

Diagnosis and Management of Exercise-induced Laryngeal Obstruction (EILO): Initial Results of a Multidisciplinary Team.

Impact of treatment adherence and inhalation technique on asthma outcomes of pediatric patients: a longitudinal study.

Inhaler Technique Questionnaire (InTeQ) in pediatric patients with asthma

Cost-effectiveness of omalizumab for the treatment of severe pediatric allergic asthma-Results of a real-life study in Spain.

Montelukast in paediatric asthma and allergic rhinitis: a systematic review and meta-analysis

Antibodies to SARS-CoV-2 in patients with primary immunodeficiencies treated with nonspecific immunoglobulins

Smartphone App for monitoring Asthma in children and adolescents

Severe COVID-19 pneumonia in Good syndrome with a favorable outcome

Collaborators (4)

Alexandra Lelia Dima

Victor Zamora

Laura Moreno-Galarraga

Yolanda Pardo

Make your next move.